Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-19

Clinical Trial Update: Effect of Celecoxib on Markers of Vascular Inflammation [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Celecoxib's effect on markers of vascular inflammation in patients with hypertension and coronary artery disease; the study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Celecoxib (Celecoxib)

Snippet

Sponsor: University of Florida | Conditions: Hypertension and Coronary Artery Disease | Phase 4 | Status: COMPLETED